Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor.
- DOI
- 10.1016/j.mam.2025.101412
- Published
- 2025 Dec
- Container
- Molecular aspects of medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.mam.2025.101412,
title = {Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor.},
author = {Jimeno J and Varona JF and Lopez-Martin JA and Izquierdo-Useros N and Molina Molina E and Guisado-Vasco P and Sachse M and Risco C and Losada A and Fudio S and Luepke E and Nieto A and Gomez J and Aviles P and Cuevas C and Bouhaddou M and Sola I and Krogan NJ and Enjuanes L and Fernandez-Sousa JM and GarcÍa-Sastre A and White K},
year = {2025},
journal = {Molecular aspects of medicine},
doi = {10.1016/j.mam.2025.101412},
url = {https://doi.org/10.1016/j.mam.2025.101412}
}RIS
TY - JOUR TI - Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor. AU - Jimeno J AU - Varona JF AU - Lopez-Martin JA AU - Izquierdo-Useros N AU - Molina Molina E AU - Guisado-Vasco P AU - Sachse M AU - Risco C AU - Losada A AU - Fudio S AU - Luepke E AU - Nieto A AU - Gomez J AU - Aviles P AU - Cuevas C AU - Bouhaddou M AU - Sola I AU - Krogan NJ AU - Enjuanes L AU - Fernandez-Sousa JM AU - GarcÍa-Sastre A AU - White K PY - 2025 JO - Molecular aspects of medicine DO - 10.1016/j.mam.2025.101412 UR - https://doi.org/10.1016/j.mam.2025.101412 ER -
APA
J, J., JF, V., JA, L., N, I., E, M. M., P, G., M, S., C, R., A, L., S, F., E, L., A, N., J, G., P, A., C, C., M, B., I, S., NJ, K., L, E., JM, F., A, G., & K, W. (2025). Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor.. Molecular aspects of medicine. https://doi.org/10.1016/j.mam.2025.101412
Source records
- pubmed · retrieved 2026-09-25T13:25:02.500Z